The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the ...
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. Unprofi...
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-...
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Neogen (NASDAQ:NEOG) and its ...
What Happened? A number of stocks fell in the afternoon session after the renewed Iran-UAE incident reignited concerns about input cost inflation and global ...
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
What a fantastic six months it’s been for Neogen. Shares of the company have skyrocketed 53.5%, hitting $9.46. This was partly thanks to its solid quarterly ...
Neogen’s first quarter results were shaped by contrasting trends across its business lines. Management cited continued core growth in the Food Safety segment...
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Life sciences company Neogen (NASDAQ:NEOG) reported Q1 CY2026 results beating Wall Street’s revenue expectations, but sales fell by 4.4% year on year to $211...
Life sciences company Neogen (NASDAQ:NEOG) reported Q1 CY2026 results topping the market’s revenue expectations, but sales fell by 4.4% year on year to $211....
Life sciences company Neogen (NASDAQ:NEOG) will be announcing earnings results this Thursday before the bell. Here’s what to expect. Neogen beat analysts’ re...
What Happened? A number of stocks jumped in the afternoon session after the government announced a surprise increase in payment rates for Medicare Advantage ...
Neogen Corporation (NASDAQ: NEOG) to release Q3 earnings on April 9. Analysts expect 5 cents/share, down from 10 cents last year. Stock rose 1.6% on Monday.
Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined approach is necessary because many ...
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.
